(US) endonovo therapeutics (otcqb: endv) is an innovative biotechnology company developing a bioelectronic approach to regenerative medicine. endonovo's immunotronics™ platform is a non-invasive, non-implantable bioelectronic device for treating/preventing vital organ failure through the reduction of inflammation and necrosis, and the promotion of regeneration. endonovo's cytotronics™ platform provides for a method of expanding and manipulating cells using simulated microgravity and time-varying electromagnetic fields (tvemf) for tissue engineering and cell therapies.